Abstract
Background: Melanoma is a cancer of the skin with potential to spread to other organs and is responsible for most deaths due to skin cancer. It is imperative to identify immune biomarkers for early melanoma diagnosis and treatment.Results: 63 immune-related genes of the total 1039 unique IRGs retrieved were associated with overall survival of melanoma. A multi-IRGs classifier constructed using eight IRGs showed a powerful predictive ability. The classifier had better predictive power compared with the current clinical data. GSEA analysis showed multiple signaling differences between high and low risk score group. Furthermore, biomarker was associated with multiple immune cells and immune infiltration in tumor microenvironment.Conclusions: The immune-related genes prognosis biomarker is an effective potential prognostic classifier in the immunotherapies and surveillance of melanoma.Methods: Melanoma samples of genes were retrieved from TCGA and GEO databases while the immune-related genes (IRGs) were retrieved from the ImmPort database. WGCNA, Cox regression analysis and LASSO analysis were used to classify melanoma prognosis. ESTIMATE and CIBERSORT algorithms were used to explore the relationship between risk score and tumor immune microenvironment. GSEA analysis was performed to explore the biological signaling pathway.
Highlights
Melanoma is a life-threatening malignancy with high metastasis and mortality rates [1, 2]
The red module showed the highest correlation with the overall survival of melanoma
The blue module was highly correlated with the overall survival of melanoma
Summary
Melanoma is a life-threatening malignancy with high metastasis and mortality rates [1, 2]. High mortality rates result from poor prognosis leading to late diagnosis. Differences in the overall survival associated with TNM stage method are observed [8]. Current studies on tumors have revealed the clinical limitations of TNM stage method [9, 10]. There is a need to explore new melanoma markers to guide the clinical treatment and improve melanoma prognosis. It is imperative to identify immune biomarkers for early melanoma diagnosis and treatment. Results: 63 immune-related genes of the total 1039 unique IRGs retrieved were associated with overall survival of melanoma. GSEA analysis showed multiple signaling differences between high and low risk score group. Conclusions: The immune-related genes prognosis biomarker is an effective potential prognostic classifier in the immunotherapies and surveillance of melanoma. GSEA analysis was performed to explore the biological signaling pathway
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
